Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Neural Regulation01:37

Neural Regulation

40.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.0K
Disorders of the Autonomic Nervous System01:18

Disorders of the Autonomic Nervous System

823
The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's...
823
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

708
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
708
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

78
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
78
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

56
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
56
Drugs Acting on Autonomic Ganglia: Blockers01:28

Drugs Acting on Autonomic Ganglia: Blockers

1.2K
Ganglionic blockers inhibit autonomic activity by blocking nicotinic receptors in the autonomic ganglia, suppressing impulse transmission. These blockers lack selectivity between sympathetic and parasympathetic ganglia and are ineffective as neuromuscular junction antagonists. They can be categorized into two groups:
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pure Autonomic Failure and Central Synucleinopathy Risk.

JAMA neurology·2026
Same author

Why the Second-Hit Hypothesis Merits Center Stage in Peripherally Induced Movement Disorders?

Movement disorders : official journal of the Movement Disorder Society·2025
Same author

Clinical Reasoning: A 66-Year-Old Man With Chronic Orthostatic Hypotension.

Neurology·2025
Same author

Interoception in Parkinson's disease: A narrative review and framework for translational research.

Autonomic neuroscience : basic & clinical·2025
Same author

Carbidopa: beyond Parkinson's disease.

Clinical autonomic research : official journal of the Clinical Autonomic Research Society·2025
Same author

Catatonia Classification and Deep Phenotyping: The Effect of Affect Must Not Be Overlooked.

Movement disorders : official journal of the Movement Disorder Society·2024
Same journal

Acetazolamide-Responsive Exertion-Triggered Episodic Ataxia in DHDDS-Related Congenital Disorder of Glycosylation.

Movement disorders clinical practice·2026
Same journal

Epileptic-Dyskinetic Encephalopathy in Snijders Blok-Campeau Syndrome: Expanding the Phenotypic Spectrum.

Movement disorders clinical practice·2026
Same journal

Hardware Sophistications in Subthalamic Nucleus Deep Brain Stimulation for Parkinson's Disease; Is the Juice Worth the Squeeze?

Movement disorders clinical practice·2026
Same journal

Correction to "Advancing Neuromodulation for Functional Movement Disorders: A Contemporary Narrative Review of Evidence, Gaps, and Future Outlook".

Movement disorders clinical practice·2026
Same journal

Efficacy of IncobotulinumtoxinA (BoNT-A) Injections in Upper Limb Task-Specific and Position-Dependent Tremors.

Movement disorders clinical practice·2026
Same journal

Health-Related Quality of Life in Children with Primary Complex Motor Stereotypies.

Movement disorders clinical practice·2026
See all related articles

Related Experiment Video

Updated: Sep 12, 2025

Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay
08:33

Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay

Published on: June 25, 2019

8.3K

Approach to Cardiovascular Autonomic Dysfunction in Patients with Synucleinopathies.

Abhishek Lenka1, Paul Beach2

  • 1Department of Neurology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

Movement Disorders Clinical Practice
|August 8, 2025
PubMed
Summary
This summary is machine-generated.

Orthostatic hypotension and supine hypertension are common in synucleinopathies like Parkinson's disease. This review details their pathophysiology, diagnosis, and management for better patient outcomes.

Keywords:
Parkinson's diseasedementia with Lewy bodiesmultiple system atrophyorthostatic hypotensionsupine hypertension

More Related Videos

Technique for Intranasal Administration of α-Synuclein Aggregates
04:49

Technique for Intranasal Administration of α-Synuclein Aggregates

Published on: November 8, 2024

576
Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
10:03

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Published on: August 16, 2020

10.7K

Related Experiment Videos

Last Updated: Sep 12, 2025

Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay
08:33

Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay

Published on: June 25, 2019

8.3K
Technique for Intranasal Administration of α-Synuclein Aggregates
04:49

Technique for Intranasal Administration of α-Synuclein Aggregates

Published on: November 8, 2024

576
Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
10:03

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Published on: August 16, 2020

10.7K

Area of Science:

  • Neurology
  • Autonomic Neuroscience

Background:

  • Autonomic dysfunction, including orthostatic hypotension (OH) and supine hypertension (SH), is prevalent in synucleinopathies (Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, pure autonomic failure).
  • OH and SH contribute to adverse outcomes like cognitive decline and motor symptom exacerbation.
  • Atypical OH presentations often overlap with synucleinopathy symptoms, necessitating increased clinical awareness.

Purpose of the Study:

  • To provide a focused review on managing cardiovascular autonomic dysfunction in synucleinopathies.
  • To inform clinical decision-making and guide future research in this area.

Main Methods:

  • This study is a narrative review.
  • It comprehensively discusses the approach to OH and SH in synucleinopathies.

Main Results:

  • The review covers the pathophysiology of OH and SH in synucleinopathies.
  • It details diagnostic criteria for OH and SH.
  • Management strategies, including non-pharmacological, pharmacological, and experimental approaches, are discussed.

Conclusions:

  • Effective management of OH and SH is crucial for improving quality of life in synucleinopathy patients.
  • Further research into novel therapeutic strategies is warranted.